Education
About Us
Working with TipRanks
Follow Us
Neuronetics Inc (STIM)
NASDAQ:STIM
Earnings Data
Report Date
May 13, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.12Last Year’s EPS
-0.27Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 04, 2025
|% Change Since: 1.64%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements, including revenue growth, a transformative acquisition, and successful program implementations. However, challenges such as decreased gross margins, increased operating expenses, and a net loss were also noted. The company is confident in its growth strategy for 2025.Company Guidance
During the Neuronetics Fourth Quarter 2024 Financial and Operating Results Conference Call, several key metrics and guidance for 2025 were discussed. The company reported a total revenue of $22.5 million for Q4 2024, marking an 11% increase over the previous year. Revenue from the NeuroStar system was $3.8 million with 46 systems shipped, while U.S. treatment session revenue was $12.9 million. The U.S. clinic revenue, largely from the Greenbrook acquisition, was $4.4 million. The gross margin decreased to 66.2% from 77.6% in the prior year, primarily due to the integration of Greenbrook Clinics. Operating expenses rose to $25.8 million, a 28% increase, partly due to acquisition costs. The net loss for the quarter was $12.1 million, translating to $0.33 per share. EBITDA was reported as negative $10.5 million, with non-recurring expenses accounting for much of this figure. For 2025, Neuronetics provided revenue guidance of $145 million to $155 million, with a gross margin around 55% and operating expenses between $90 million and $98 million. The company anticipates being cash flow positive by the third quarter of 2025, bolstered by identified cost synergies and a recent $18.9 million capital raise.Revenue Growth and Greenbrook Acquisition
Total revenue for Q4 2024 was $22.5 million, an increase of 11% over Q4 2023. The acquisition of Greenbrook TMS transformed Neuronetics into a vertically integrated mental health care provider.
Better Me Provider Program Success
The BMP program expanded to over 350 sites, increasing patient volume by 36%. Practices in the BMP program are treating 3 times more patients per quarter than non-BMP practices.
FDA Clearance for Adolescent Treatment
NeuroStar received FDA clearance as the first and only TMS treatment approved as a first-line therapy for depression in adolescents aged 15 to 21, expanding the total addressable market.
Cost Synergies and Financial Flexibility
Captured over 90% of the identified $22 million in annualized cost synergies from the Greenbrook acquisition, strengthening the balance sheet and providing flexibility for growth.
---
STIM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
STIM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 04, 2025 | $4.26 | $5.06 | +18.78% |
| Nov 12, 2024 | $1.10 | $0.69 | -37.27% |
| Aug 12, 2024 | $1.78 | $0.74 | -58.43% |
| May 07, 2024 | $3.75 | $2.60 | -30.67% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Neuronetics Inc (STIM) report earnings?
Neuronetics Inc (STIM) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
What is Neuronetics Inc (STIM) earnings time?
Neuronetics Inc (STIM) earnings time is at May 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is STIM EPS forecast?
STIM EPS forecast for the fiscal quarter 2025 (Q1) is -0.12.
---